Prevention of Missed Opportunities for HIV Diagnosis by Promoting HIV Testing of Patients With Pneumococcal Pneumonia at Nice University Hospital (PneumoVIH)

Hiv Clinical Trial

— PneumoVIH  

Official title:

PneumoVIH : Prevention of Missed Opportunities for HIV Diagnosis by Promoting HIV Testing of Patients With Pneumococcal Pneumonia at Nice University Hospital

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04909268
• Other study ID #: 21Bacterio01
• Status: Recruiting
• Start date: December 1, 2020
• Est. completion date: July 31, 2022

Study information

• Verified date: May 2021
• Source: Centre Hospitalier Universitaire de Nice
• Contact: Raymond RUIMY, PhD
• Phone: +33 4 92 03 90 08
• Email: ruimy.r[@]chu-nice.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

According to usual practices, HIV testing should be performed for each patient diagnosed for pneumococcal pneumonia. Unfortunately, in 2018, only 27% of patients were tested for HIV following pneumococcal pneumonia in Nice University Hospital. The aim of PneumoVIH protocol is to promote HIV testing by reminding good practices to physicians. To achieve this, the team of the bacteriology laboratory will contact physicians for each patient positive for pneumococcal antigenuria to suggest HIV testing. This prospective public health action will aim to integrate this HIV test into routine care and to evaluate benefits through the number of HIV positive patients that will be diagnosed.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 270
• Est. completion date: July 31, 2022
• Est. primary completion date: December 31, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Male or female 18 years or older with validated diagnosis of bacterial pneumococcal pneumonia.

Exclusion Criteria:

• documented history of HIV infection.

Related Conditions & MeSH terms

• Hiv
• Pneumonia
• Pneumonia, Pneumococcal

Intervention

Diagnostic Test:
• HIV testing
serology for HIV testing

Locations

Country	Name	City	State
France	Nice University Hospital	Nice

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Nice

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Testing rate	To evaluate the implementation of the recommendations, HIV testing rate in this population during the study period will be compared with the previous year.	1 year
Secondary	Rate of HIV-positive status discovery	TEvaluating the HIV positivity in patients with bacterial pneumonia or discharged after a visit at the emergency department at the university hospital	1 year